The 2024 Canadian Paediatric Surveillance Program Annual Results are now available. The report includes preliminary results on studies such as acute life-threatening harms related to the non-medical use of opioids, stimulants, and sedatives, and final data on post-COVID-19 condition (long COVID) and hypoglycemia during treatment of acute lymphoblastic leukemia. If you are a practicing paediatrician or paediatric subspecialist in Canada and are not already part of CPSP, email CPSP@cps.ca.

The Canadian Paediatric Surveillance Program (CPSP) is looking for investigators to initiate new studies for active surveillance of low-frequency, high-impact diseases and conditions that affect Canadian children and youth. Interested investigators should contact the CPSP to discuss topics of interest and to submit their proposals before September 8, 2025 for consideration at the Fall CPSP Scientific Steering Committee meeting.

The Canadian Paediatric Surveillance Program (CPSP) is offering paediatric and subspecialty residents a chance to apply for a $3,000 in-kind grant to conduct a one-time survey through the CPSP. The application deadline is September 15, 2025. More info here

The Canadian Paediatric Surveillance Program has launched a study on neonatal hyperbilirubinemia – severe (NHS). The study will gather epidemiologic data about NHS in light of a new CPS position statement on neonatal hyperbilirubinemia and compare results of the two prior CPSP studies.